trevicta (previously paliperidone janssen)
janssen-cilag international nv - paliperidonpalmitat - schizofreni - psykoleptiske - trevicta, en 3 månedlig injeksjon, er angitt for vedlikeholdsbehandling av schizofreni hos voksne pasienter som er klinisk stabile på 1 månedlig injeksjonsprodukt av paliperidonpalmitat.
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
carbamazepine essential pharma 125 mg
essential pharma (m) limited - karbamazepin - stikkpille - 125 mg
carbamazepine essential pharma 250 mg
essential pharma (m) limited - karbamazepin - stikkpille - 250 mg
tegretol 200 mg
novartis norge (2) - karbamazepin - tablett - 200 mg
tegretol 20 mg/ ml
novartis norge (2) - karbamazepin - mikstur, suspensjon - 20 mg/ ml
tegretol 100 mg
novartis norge (2) - karbamazepin - tablett - 100 mg
tegretol retard 400 mg
novartis norge (2) - karbamazepin - depottablett - 400 mg
tegretol retard 200 mg
novartis norge (2) - karbamazepin - depottablett - 200 mg
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidonpalmitat - schizofreni - psykoleptiske - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.